<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of this overview is to discuss the changes in the 2008 WHO classification of myeloid <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, with exclusion of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Specific mutations or rearrangements leading to constitutive activation of growth factor receptors or cytoplasmic tyrosine kinases are now recognised as recurrent genetic events characterising the group of myeloproliferative <z:hpo ids='HP_0002664'>neoplasms</z:hpo> (MPN) </plain></SENT>
<SENT sid="2" pm="."><plain>A newly introduced subgroup consists of patients with persistent <z:hpo ids='HP_0001880'>eosinophilia</z:hpo> and myeloid or lymphoid proliferations harbouring specific genetic changes involving platelet-derived growth factor receptors alpha and beta (PDGFRA and PDGFRB) or fibroblast growth factor receptor 1 (FGFR1) </plain></SENT>
<SENT sid="3" pm="."><plain>The clinical relevance of recognising myeloid <z:hpo ids='HP_0002664'>neoplasms</z:hpo> with aberrant tyrosine kinase activity is based in novel treatment options with <z:chebi fb="0" ids="38637">tyrosine kinase inhibitors</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) without increased blasts are further divided into subtypes of refractory cytopaenias with unilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>A new provisional entity is refractory cytopaenia of childhood </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e>- and therapy-related myeloid <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, including <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, were moved to the section of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> and related precursor <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
</text></document>